The antitumor efficacy of the IL3RA-ADC BAY-943 was tested in two IL3RA-positive, systemic (intravenous transplantation) cell line-derived xenografts: MOLM-13 human AML and MV-4-11 human biphenotypic leukemia models in mice. Here, IL3RA is linked to acute myeloid leukemia.